<DOC>
	<DOCNO>NCT00679978</DOCNO>
	<brief_summary>Osteoporotic vertebral fracture ( VF ) osteonecrosis femoral head ( OFH ) major concern patient systemic rheumatic disease treat high-dose glucocorticoid ( GCs ) . The investigator examine compare incidence risk factor VF OFH patient recently receive high-dose GC therapy clarify relationship two complication .</brief_summary>
	<brief_title>Vertebral Fracture Osteonecrosis Associated With High-dose Glucocorticoid</brief_title>
	<detailed_description>Patients rheumatic disease receive GCs ( ≧0.5 mg/kg/day prednisolone equivalent ) within past 2 month enrol study , treat 200 mg/day etidronate cyclically . The bone mineral density ( BMD ) lumbar spine ( L2-4 ) examine QDR2000 . OFH evaluate magnetic resonance imaging ( MRI ) . ClinicalTrials.gov identifier : NCT00679978 . Forty-four patient complete 2-year study include annual X-rays BMD analysis . MRI evaluation entry 2 year perform 41 patient . The BMD value anteroposterior ( AP ) lateral view decrease 6.4 % 9.7 % respectively first year , stable second year . Eleven patient develop VF 9 patient develop OFH . The risk factor VF include previous VF low BMD value ( T score &lt; -1.5 ) AP view baseline odds ratio ( OR ) 14.9 ( 95 % CI 2.9-76.4 ) , risk factor OFH recent maximum GC dosage ( &gt; 1.2 mg/kg/day versus ≦ ; OR=7.7 , 95 % CI 1.3-45.5 ) decrease BMD value lateral view ( &gt; 15 % versus ≤ ; OR=6.7 , 95 % CI 1.2-36.1 ) first year .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Patients admit hospital treatment active systemic rheumatic disease take least 0.5 mg/kg/day PSL equivalent January 2001 June 2003 eligible prospective study Patients appropriate study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>glucocorticoid</keyword>
	<keyword>bone mineral density</keyword>
	<keyword>osteonecrosis femoral head</keyword>
</DOC>